Lymphocytopenia considering GST genotype and changes in mitochondrial activity under dimethyl fumarate (DMF) treatment in Multiple Sclerosis

被引：0
|
作者：
Werntze, Neele [1 ]
Haupeltshofer, Steffen [2 ,3 ]
Blusch, Alina [1 ]
Lemhoefer, Katharina [1 ]
Skrygan, Marina [4 ]
Susok, Laura [4 ]
Gold, Ralf [1 ]
Gambichler, Thilo [4 ,5 ]
Ellrichmann, Gisa [6 ]
机构：
[1] Catholic Hosp Bochum St Josef Hosp, Dept Neurol, Bochum, Germany
[2] Essen Univ Hosp, Dept Neurol, Essen, Germany
[3] Ctr Translat Neuro & Behav Sci, Essen, Germany
[4] Catholic Hosp Bochum St Josef Hosp, Dept Dermatol, Bochum, Germany
[5] Christian Hosp Unna, Dept Dermatol, Unna, Germany
[6] Klinikum Dortmund gGmbH, Clin Ctr Mitte, Dept Neurol, Dortmund, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1515/2398
引用
收藏
页码：967 / 967
页数：1
相关论文
共 50 条
  • [41] Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients
    Baharnoori, Moogeh
    Wilson, Ryan
    Saxena, Shrishti
    Gonzalez, Cindy T.
    Sotiropoulos, Marinos G.
    Keyhanian, Kiandokht
    Healy, Brian C.
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [42] COST EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE VERSUS TERIFLUNOMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Ruiz, L.
    Machado, L.
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Harrington, A.
    VALUE IN HEALTH, 2017, 20 (09) : A724 - A724
  • [43] Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects
    Linker, Ralf A.
    Gold, Ralf
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (11)
  • [44] Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: one year experience
    Vollmer, B. L.
    Nair, K.
    Sillau, S. H.
    Strobel, M.
    Robinson, L.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 536 - 536
  • [45] Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: two year experience
    Vollmer, B. L.
    Nair, K. V.
    Sillau, S. H.
    Corboy, J.
    Vollmer, T. L.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 341 - 341
  • [46] Successful treatment with dimethyl fumarate in a child with relapsing-remitting multiple sclerosis
    Saijo, Naoya
    Abe, Yu
    Oikawa, Yoshitsugu
    Okubo, Yukimune
    Endo, Wakaba
    Numata-Uematsu, Yurika
    Takahashi, Toshiyuki
    Uematsu, Mitsugu
    BRAIN & DEVELOPMENT, 2022, 44 (05): : 353 - 356
  • [47] Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects
    Ralf A. Linker
    Ralf Gold
    Current Neurology and Neuroscience Reports, 2013, 13
  • [48] Behavior of lymphocytary subpopulations during treatment with dimethyl fumarate in patients with multiple sclerosis
    Manez Sierra, Minerva
    Rodriguez Belli, Agustin
    Delgado Gil, Virginia
    Padilla Parrado, Fransciso
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [49] Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis
    Losavio, Francesco Antonio
    Lucchini, Matteo
    De Fino, Chiara
    Mirabella, Massimiliano
    Nociti, Viviana
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 7 : 68 - 69
  • [50] Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies
    Diaz, Gwendoline Montes
    Hupperts, Raymond
    Fraussen, Judith
    Somers, Veerle
    AUTOIMMUNITY REVIEWS, 2018, 17 (12) : 1240 - 1250
12345